The latest version of the software enables researchers to quickly integrate and understand multiple lines of experimental evidence from either publicly available or proprietary data sources.
“These enhancements really position IPA as a powerful tool for disease research,” stated Brigitte Ganter Ph.D., Director of Product Management, Ingenuity Systems. “By incorporating multiple data sources, researchers gain confidence in assertions about their data. They can now map, analyze, and integrate SNP, microRNA, and gene expression data to rapidly identify common pathways, molecular interactions, cellular phenotypes, and disease-related phenotypes that might lie at the core of mechanism of disease or drug response.”
Additional new tools in IPA 7.5 enable researchers to bring a wide range of data together for better biological understanding:
- Updated mapping and comparison tools for rapid data assessment
- Additional Path Designer tools for customization of pathway graphics
- SBML pathway import (beta) for the creation of custom pathway libraries
- New disease-focused content including 46 new signaling pathways
IPA is an all-in-one software application that enables researchers to model, analyze, and understand the complex biological and chemical systems at the core of life science research. IPA’s search capabilities provide users with access to the highest quality detail-rich knowledge available on genes, drugs, chemicals, protein families, cellular and disease processes, and signaling and metabolic pathways. IPA supports analysis of data from all experimental platforms, and is used at all stages of the drug discovery and development process, including target identification and validation, biomarker discovery, molecular toxicology, metabolomics, and pharmacogenomics. IPA has been broadly adopted and cited in hundreds of peer-reviewed journals.
About Ingenuity Systems®
Ingenuity Systems is a leading provider of information solutions and custom services for life science researchers, computational biologists and bioinformaticists, and life science industry suppliers. Our long-term focus on innovation in semantic search has allowed us to create groundbreaking technologies that have one common goal —to generate maximum value from all types of biological and chemical knowledge. Ingenuity offerings leverage the Ingenuity Knowledge Base, which contains uniquely structured literature findings that allow scientists to ask complex biological questions and gain rapid insight into their experimental data or systems of interest. Today, Ingenuity’s solutions are used by thousands of researchers at hundreds of leading pharmaceutical, biotechnology, academic, and government research institutions worldwide. For more information visit: www.ingenuity.com